Givaudan stock faces US antitrust trial risk after court ruling
Published on 11/13/2026 at 12:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLegal Risk Remains Unresolved
- A New Jersey federal judge allowed antitrust claims against Givaudan and other fragrance-ingredient makers to proceed.
- The ruling addresses the sufficiency of the allegations and does not establish liability or damages.
- Potential litigation costs, remedies and management attention remain relevant as the case advances.
Givaudan faces continued legal pressure in the United States after a federal judge allowed price-fixing claims involving fragrance-ingredient makers to proceed toward a possible trial. The ruling keeps litigation risk in focus without establishing that Givaudan inflated prices.
Court Keeps Claims Alive
Judge William J. Martini of the US District Court for the District of New Jersey issued the opinion on November 9, 2026. In the case involving Givaudan, Symrise and other fragrance companies, the judge denied the defendants' motion for judgment on the pleadings.
According to Bloomberg, the plaintiffs, including businesses and consumers, adequately alleged price-fixing under the Sherman Act and state antitrust laws. Martini said the alleged conduct should be assessed as horizontal price-fixing between competitors at the same market level.
The decision is procedural. It allows the claims to continue and potentially move toward trial, but it does not determine whether Givaudan or the other defendants are liable. It also sets no damages figure or other financial remedy.
Investor Focus Shifts To Exposure
For investors, the ruling extends the period in which legal costs, potential remedies and management time may affect the risk assessment. The decision does not quantify Givaudan's possible exposure, so the financial effect remains open as the proceedings develop.
Givaudan stock traded at 4,410.50 euros on Lang & Schwarz at 12:17 CET on Friday, November 13, 2026. The quote was taken during the European session, without a verified dated Xetra closing comparison.
Givaudan Stock At A Glance
- Company: Givaudan SA
- ISIN: CH0010645932
- WKN: 938427
- Exchange: Lang & Schwarz
- Price: 4,410.50 euros at 12:17 CET on November 13, 2026
The broader Swiss market can be followed through the SMI.
Further legal filings and court decisions will determine whether the claims advance beyond the current stage. More news and analyses on Givaudan stock.
